These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1418836)

  • 1. A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.
    Johnson BF; Frishman WH; Brobyn R; Brown RD; Reeves RL; Wombolt DG
    Am J Hypertens; 1992 Oct; 5(10):727-32. PubMed ID: 1418836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine versus atenolol in essential hypertension.
    Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
    Am J Cardiol; 1994 Jan; 73(3):50A-54A. PubMed ID: 8310977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension.
    Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S103-6. PubMed ID: 2467116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial.
    Hong SJ; Ahn TH; Baek SH; Cho WH; Jeon HK; Kwan J; Yoon MH; Lee KJ; Lim DS
    Clin Ther; 2006 Apr; 28(4):537-51. PubMed ID: 16750465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension.
    Mehta JL; Lopez LM; Vlachakis ND; Gradman AH; Nash DT; O'Connell MT; Garland WT; Pickering BI
    Am Heart J; 1993 Jun; 125(6):1704-10. PubMed ID: 8498314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension.
    de Bruijn B; Cocco G; Tyler HM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S107-9. PubMed ID: 2467117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension.
    Maclean D; Mitchell ET; Lewis R; Irvine N; McLay JS; McEwen J; Coulson RR; Slater ND; Fitzsimons TJ; McDevitt DG
    Br J Clin Pharmacol; 1990 Apr; 29(4):455-63. PubMed ID: 2183868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients.
    Pareek A; Salkar H; Mulay P; Desai S; Chandurkar N; Redkar N
    Am J Ther; 2010; 17(1):46-52. PubMed ID: 19535971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients.
    Mroczek WJ; Burris JF; Allenby KS
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S79-84. PubMed ID: 2467136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension.
    Burris JF; Ames RP; Applegate WB; Ram CV; Davidov ME; Mroczek WJ
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S98-102. PubMed ID: 2467140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of amlodipine and verapamil in the treatment of mild to moderate hypertension.
    Lorimer AR; Smedsrud T; Walker P; Tyler HM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S89-93. PubMed ID: 2467138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo.
    Kuschnir E; Acuña E; Sevilla D; Vasquez J; Bendersky M; Resk J; Glazer R
    Clin Ther; 1996; 18(6):1213-24. PubMed ID: 9001838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.